within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AC05_Lanadelumab;
model Lanadelumab 
   extends Pharmacolibrary.Drugs.ATC.B.B06AC05;

  annotation(Documentation(
    info ="<html><body><p>Lanadelumab is a fully human monoclonal antibody that inhibits plasma kallikrein and is used as a prophylactic treatment to prevent attacks of hereditary angioedema (HAE) in patients aged 12 years or older. It is approved by regulatory agencies including the FDA and EMA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy volunteers and patients with hereditary angioedema (HAE), based on population pharmacokinetic analysis. Subjects included males and females, mainly adults, with subcutaneous administration.</p><h4>References</h4><ol><li><p>Syed, YY (2018). Lanadelumab: First Global Approval. <i>Drugs</i> 78(15) 1633–1637. DOI:<a href=&quot;https://doi.org/10.1007/s40265-018-0987-2&quot;>10.1007/s40265-018-0987-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30267321/&quot;>https://pubmed.ncbi.nlm.nih.gov/30267321</a></p></li><li><p>Wang, Y, et al., &amp; Martin, P (2020). Pharmacokinetics, Pharmacodynamics, and Exposure-Response of Lanadelumab for Hereditary Angioedema. <i>Clinical and translational science</i> 13(6) 1208–1216. DOI:<a href=&quot;https://doi.org/10.1111/cts.12806&quot;>10.1111/cts.12806</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32407574/&quot;>https://pubmed.ncbi.nlm.nih.gov/32407574</a></p></li><li><p>Hwang, G, et al., &amp; Craig, T (2019). A review of kallikrein inhibitor lanadelumab in hereditary angioedema. <i>Immunotherapy</i> 11(11) 937–944. DOI:<a href=&quot;https://doi.org/10.2217/imt-2018-0197&quot;>10.2217/imt-2018-0197</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31234673/&quot;>https://pubmed.ncbi.nlm.nih.gov/31234673</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Lanadelumab;
